CORPORATE NEWS & MEDIA*

NEWS RELEASE: Sigma-Tau Pharmaceuticals, Inc. Signs Exclusive Agreement with Crosscare Limited for U.S. Marketing and Distribution License of Colief® Infant Drops for the Treatment of Colic-Associated Crying

GAITHERSBURG, MD and OAKBROOK TERRACE, IL, August 11, 2014 — Sigma-Tau Pharmaceuticals, Inc. (Sigma-Tau) today announced that the Company has signed an exclusive U.S. license agreement with Crosscare of Dublin, Ireland, to market and distribute Colief® Infant Drops for the treatment of colic.

Read more ...

Press Enquiries

For specific press enquires please contact:


FLEISHMAN HILLARD

Bankside 2 

100 Southwark Street

London

SE1 0SW

+44 (0) 20 7306 9000

Our Commitment

OUR COMMITMENT is to provide support and educational resources to both consumers, as well as Healthcare Professionals.
Learn more